Logo

LAMP

Lucira Health Files for Chapter 11 Bankruptcy, Signals Intent to Sell Business

The COVID-19 test kit maker cited waning demand for its COVID-19 tests and unexpected delays in authorization for its combination COVID-19 and influenza test.

Startup RT MicroDx Aiming to Disrupt OTC Space with Disposable Strep Spit MDx
Premium

The Boston-based company has developed a loop-mediated amplification assay and a novel lateral flow strip technology.

Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium

The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.

KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada

The palm-sized single-use instrument uses shallow nasal swabs and nucleic acid amplification to identify COVID-19 and influenzas A and B.

Lucira Health Molecular COVID/Flu Test Gets FDA Emergency Use Authorization

According to the agency, this is the first molecular COVID-19 test to receive FDA authorization following collaboration with the NIH's Independent Test Assessment Program (ITAP).

Oct 19, 2022

Aptitude Medical Gets FDA EUA for Over-the-Counter COVID Saliva MDx

Oct 14, 2022

Lucira Health Makes Progress with STI Panel, Prepares Rollout of Digital Health Platform
Premium

Aug 31, 2022

Mammoth Biosciences Develops SNP-Detecting CRISPR System for SARS-CoV-2 Variant Surveillance
Premium

Aug 19, 2022

Penn State Portable Molecular COVID-19 Test Aims to Fill Gap Between Antigen and Molecular Tests
Premium

Jul 15, 2022

Imperial College Spinout ProtonDx Plans Commercialization of Rapid Molecular Dx Instrument
Premium

Jun 7, 2022

DxLab Receives FDA Emergency Use Authorization For RT-LAMP COVID-19 Test

May 26, 2022

Domus Diagnostics to Launch Point-of-Care Infectious Disease Molecular Diagnostics Test System
Premium

May 2, 2022

Dx Startup Detect Preparing to Roll Out Next-Gen Molecular Instrument, Broaden Test Menu
Premium

Mar 17, 2022

Anavasi Diagnostics Poised to Debut Rapid POC MDx System, COVID-19 Test
Premium

Feb 8, 2022

Lucira Health Enters Debt Facility of up to $80M

Feb 3, 2022

UK Researchers Develop Low-Cost Molecular COVID-19 Testing in a Backpack
Premium

Feb 1, 2022

Cheap, Rapid 'Flurona' Test Developed by UCSB Solves Problems With LAMP Sensitivity
Premium

Jan 18, 2022

Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark

Jan 13, 2022

UIC Researchers Using Optimized RT-Lamp Technology for Low-Cost COVID-19 Testing
Premium

Dec 8, 2021

Genedrive Rapid Molecular COVID-19 Test Receives CE Mark

Nov 9, 2021

Anavasi Diagnostics Awarded $14.9M NIH Grant for Rapid Molecular SARS-CoV-2 Test

May 18, 2021

Genomtec Gets CE-IVD Mark for Saliva-Based Molecular SARS-CoV-2 Test

Apr 26, 2021

Lucira Health SARS-CoV-2 Self-Test Receives Health Canada Conditional Authorization

Apr 12, 2021

Lucira Health Nabs OTC EUA for SARS-CoV-2 Test, Expects Q1 Revenues of up to $4.5M

Mar 23, 2021

FDA Grants EUAs for Direct-to-Consumer Versions of Color Coronavirus Test, Sample Collection Kit

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.